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Abstract
Background: Adeno-associated virus (AAV) type 2 is an important virus due to its use as a safe
and effective human gene therapy vector and its negative association with certain malignancies.
AAV, a dependo-parvovirus, autonomously replicates in stratified squamous epithelium. Such tissue
occurs in the nasopharynx and anogenitals, from which AAV has been clinically isolated. Related
autonomous parvoviruses also demonstrate cell tropism and preferentially replicate in
oncogenically transformed cells. Combining these two attributes of parvovirus tropism, squamous
and malignant, we assayed if AAV might replicate in squamous cervical carcinoma cell isolates.
Results:  Three primary isolates (PT1-3) and two established cervical cancer cell lines were
compared to normal keratinocytes (NK) for their ability to replicate AAV. One isolate, PT3,
allowed for high levels of AAV DNA replication and virion production compared to others. In
research by others, four cellular components are known required for in vitro AAV DNA replication:
replication protein A (RPA), replication factor C (RFC), proliferating cell nuclear antigen (PCNA),
and DNA polymerase delta (POLD1). Thus, we examined PT3 cells for expression of these
components by DNA microarray and real-time quantitative PCR. All four components were over-
expressed in PT3 over two representative low-permissive cell isolates (NK and PT1). However,
this super-permissiveness did not result in PT3 cell death by AAV infection.
Conclusion: These data, for the first time, provide evidence that these four cellular components
are likely important for AAV in vivo DNA replication as well as in vitro. These data also suggest that
PT3 will be a useful reagent for investigating the AAV-permissive transcriptome and AAV anti-
cancer effect.
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Background
As adeno-associated virus (AAV) increases in popularity as
a gene therapy vector [1-6] we need to improve our under-
standing of the molecular biology of AAV replication. This
will allow for better manipulation of AAV replication and,
ultimately, should greatly boost rAAV production. Fur-
thermore, while certain groups fail to see a correlation [7-
9], the vast majority of epidemiologic, animal, and tissue
culture studies strongly suggest that AAV inhibits the car-
cinogenesis process [10-29]. Moreover, there is a long his-
tory of AAV functioning as an autonomous parvovirus
during specific circumstances. Yakobson et al. (1987) first
observed the ability of AAV to replicate productively with-
out helper virus in cells at low levels [30]. Others have
demonstrated that a few cell lines, such as COS-7 cells,
would allow for autonomous AAV replication [30-32]. All
of these early studies utilized oncogenically transformed
cells and in most circumstances the cells had to be treated
with a genotoxic/synchronizing agent to achieve low level
AAV replication. In a more recent study Wang and Srivas-
tava (1998) demonstrated that mutation of the Rep78
binding site within the AAV p5 promoter allowed for low
levels of autonomous AAV replication without genotoxic
agents in HeLa cells [33].
We have been studying autonomous AAV replication in
differentiating primary normal keratinocytes (NK) as they
form a stratified squamous epithelium (SSE) [34-36]. AAV
virus particle arrays have been identified in the nucleus of
AAV infected differentiated keratinocytes with no concur-
rent adenovirus infection [34]. We hypothesized that AAV
might replicate autonomously in SSE as AAV has been iso-
lated from SSE at multiple body sites, including the ano-
genital region and the nasopharynx [37-39]. In
continuing these studies primary squamous cervical can-
cer isolates and cell lines were surveyed for their ability to
allow for AAV DNA replication. One primary isolate, PT3,
was identified which allowed for 10 fold higher AAV DNA
replication levels than NK and other cervical cancer cell
lines [40]. In this study no genotoxic or cell synchronizing
agents were used. The PT3 AAV super-permissive cell iso-
late offers us a unique reagent which might be useful in
several ways. One use is to identify cellular genes that are
needed for AAV autonomous replication by comparing
the PT3 transcriptome to cells which allow only low AAV
replication levels. The discovery of cellular helper and
inhibitor genes for AAV will likely be very useful for
increasing production of recombinant AAV virus for
human gene therapy as well as for a better understanding
of AAV's life cycle.
An important part of the molecular biology of AAV are the
cellular proteins intimately involved in AAV DNA replica-
tion. In fact, a series of such proteins have already been
identified to be directly involved in AAV in vitro DNA rep-
lication. These cellular components are replication pro-
tein A (RFA), replication factor C (RFC), proliferating cell
nuclear antigen (PCNA), and DNA polymerase delta
(PolD1)[41,42]. These proteins have also been shown to
help minute virus of mice (MVM), an autonomous parvo-
virus [43]. To our knowledge only PT3 has been described
as being super-permissive for AAV replication. Thus, to
better characterize PT3, in this study we analyzed the RNA
expression of these known replication proteins in PT3
cells compared to normal keratinocytes (NK) and another
primary cervical cancer isolate, PT1. These latter two cell
types allow only much lower levels of AAV DNA replica-
tion. It was found that all 4 of these cellular replication
components are up-regulated in high AAV-permissive PT3
versus low-permissive PT1 or NK.
Results
AAV2 replicates significantly higher in PT3 cells
AAV has been isolated from SSE of the anogenitals and
autonomous parvoviruses preferentially replicate in
malignant cells. Thus, to test the hypothesis that AAV pref-
erentially replicates in cervical cancer cells we compared
three primary cervical cancer isolates and two archival cer-
vical cancer cell lines to normal primary human foreskin
keratinocytes (NK) for the ability to allow AAV autono-
mous replication and virion production within the organ-
otypic epithelial raft culture system. All of these cells,
except the normal keratinocytes, contain human papillo-
mavirus type 16 (HPV-16) DNA. The NK cells represent a
mixed culture of cells isolated from multiple individuals.
The six types of cells were infected with AAV, transferred
into the raft culture system to form a stratified squamous
epithelium, harvested on day 6, DNA extracted, and ana-
lyzed by Southern blot. Two types of analyses were done
as depicted in Figure 1A. First, AAV DNA replication was
analyzed in the various squamous cell lines as SSE rafts, as
a "first plate" analysis. Second, AAV virion production was
measured by generating putative AAV virus stocks from
equivalent "first plate" rafts and then a portion was used
to infect a "second plate" of adenovirus-infected HEK293
cells. Any AAV DNA replication in the 293 cells would be
due to AAV virions produced in the first plate rafts.
The Southern blot analysis of AAV replication directly in
the first plate rafts is shown in Figure 1B. As can be seen,
of the six cell types one isolate showed an unusually high
level of AAV replication compared to other isolates. PT3
allowed for approximately a 10 fold higher level of AAV
DNA replication compared to all other cervical cancer cell
lines by densitometric analysis. All the other cervical can-
cer lines, and normal keratinocytes, also demonstrated
AAV replication, but at a much low level. A quantification
of the DNA replication levels is shown in Figure 1C. These
results are comparable to a similar first plate raft experi-
ment of AAV DNA replication shown in Figure 1D. How-BMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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High AAV replication and virion production in PT3 cells Figure 1
High AAV replication and virion production in PT3 cells. Equal numbers of the indicated cells were infected with AAV, 
cultured in the organotypic epithelial raft system and analyzed for AAV DNA replication and virion production as described in 
the materials and methods section. A shows the experimental scheme. B shows the resulting level of AAV DNA replication in 
a "first plate" experiment done in triplcate. Note that PT3 allows for the highest level of AAV DNA replication. C shows a den-
sitometric quantification of the experiment shown in B. D shows the resulting level of AAV DNA replication in a "first plate" 
experiment, similar to that done in B, however the monomer duplex (md) and single stranded (ss) bands are not as overex-
posed as in B. E shows the level of AAV virion production by infection and replication in a "second plate" of adenovirus-
infected 293 cells. Again, note that PT3 allows for the highest level of AAV virion production.BMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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ever, coupled with this experiment is a second plate
analysis of AAV virion production as shown Figure 1E.
Note that PT3 was, in addition to higher AAV DNA levels,
also demonstrated higher levels of virion production as
well. Thus, PT3 is super permissive for complete AAV's full
life cycle.
Gene expression analysis with normalization to ACTB, 
GAPDH, or HG-U133A housekeeping genes
As PT3 allowed much higher levels of AAV replication we
expected these cells to over express cellular components
PCNA, POLD1, RFC, RPA1, and RPA [41,42]. Thus the
transcriptome of PT3, representing the high AAV replica-
tion scenerio, was compared to low/normal AAV replica-
tion cell types PT1 and NK by DNA microarray analysis.
Total RNA prepared from PT3, PT1 and NK was examined
for the expression levels of Affymetrix HG-U133A (14,500
human genes). The RNA samples were isolated in-house
and sent to the University of Iowa DNA Core for analysis.
Three different methods for data normalization using
ACTB, GAPDH, and Affymetrix U-133A housekeeping
expression, respectively were utilized.
In data normalization methods using ACTB as a control
housekeeping gene, all genes (6104 probe sets) we identi-
fied 1781 probe sets that changed at least 2-fold between
PT3 and non-PT3. We also found 1311 up-regulated
probe sets in PT3 and 470 down-regulated probe sets that
changed at least 2-fold in either PT1 or NK. A total of 1781
probe sets pointed at differently expressed genes. Seven
genes, members of four critical cellular components iden-
tified as essential for AAV DNA replication [41,42], were
up-regulated in PT3 compared to PT1 and NK cells. These
genes included PCNA, POLD1, RFC3, RFC4, RFC5, RPA1,
and RPA2 (Table 1), when normalized to ACTB.
Normalization of all probe sets (5789 probe sets) to
expression of GAPDH as a control gene revealed 1440
probe sets that were up-regulated, and 429 probe sets that
were down-regulated, in PT3 compared to PT1 and NK
cell lines, for a total of 1869 genes of all differently
expressed genes. Yet again the same seven AAV-critical
genes were up-regulated in PT3 compared to PT1 and NK,
(Table 1), this time when normalized to GAPDH. These
data provide evidence that the cellular components
reported to be involved in AAV in vitro DNA replication
may also be involved in vivo AAV DNA replication as well.
Furthermore these data suggest a mechanistic explanation
as to why PT3 allows high AAV DNA replication.
Affymetrix U-133A housekeeping genes normalization,
across all probe sets (4581 probe sets) on the array,
revealed 791 up-regulated and 687 down-regulated tran-
scripts in PT3 compared to PT1 and NK cell lines, for a
total of 1478 probe sets of all differently expressed genes.
Again six of seven of the same AAV-critical genes were up-
regulated in PT3 compared to PT1 and NK, (Table 1), this
time when normalized to a broad series of housekeeping
genes. Using this third control analysis, RPA1 dropped
out due to lack of statistical significance. Similar analyses
were made for cellular helicases and DNA polymerase α,
which have been suggested to be involved in AAV DNA
replication. As can be seen the data suggests that cellular
helicases DHX9 and RECQL were up-regulated in PT3
compared to PT1 and NK, however DNA2L was down-reg-
ulated (Table 2). The data also suggests that cellular DNA
polymerase α was up-regulated in PT3 compared to PT1
and NK (Table 3).
Comparison of Normalization Techniques
Based on the number of transcripts identified as differen-
tially expressed, the three techniques used to normalize
the array data could be ordered by the number of genes
identified as differentially expressed as follows: GAPDH
(1869 probe sets) > ACTB (1781 probe sets) > U-133A
(1478 probe sets). Although the three array normalization
Table 1: Expression analysis of PCNA, POLD1, RFC and RPA using three different housekeeping controls. 
Probe set Description Gene symbol PT3 Non-PT3 Fold Differences
ACTB GAPDH U133-A ACTB GAPDH U133-A ACTB GAPDH U133-A
201202_at proliferating cell nuclear antigen PCNA 13.4 13.5 13.7 11.7 11.8 12.3 3.2 3.2 2.6
203422_at polymerase (DNA directed), 
delta 1
POLD1 11.1 11.2 11.3 9.9 10.0 10.2 2.2 2.3 2.2
204128_s_at replication factor C (activator 
1) 3, 38 kDa
RFC3 11.4 11.5 11.6 9.4 9.4 9.9 4.0 4.0 3.2
204127_at replication factor C (activator 
1) 3, 38 kDa
RFC3 12.3 12.3 12.5 10.7 10.7 11.2 3.0 3.0 2.5
204023_at replication factor C (activator 
1) 4, 37 kDa
RFC4 13.3 13.4 13.6 11.3 11.4 11.9 4.0 4.0 3.3
203209_at replication factor C (activator 
1) 5, 36.5 kDa
RFC5 11.4 11.4 11.6 10.0 10.1 10.5 2.6 2.6 2.1
201528_at replication protein A1, 70 kDa RPA1 11.9 12.0 - 10.8 10.9 - 2.1 2.1 -
201529_s_at replication protein A1, 70 kDa RPA1 12.3 12.4 - 11.2 11.3 - 2.0 2.0 -
201756_at replication protein A2, 32 kDa RPA2 12.5 12.6 12.7 10.9 11.0 11.5 2.9 2.9 2.3
Three difference methods for data normalization using ACTB, GAPDH, and Affymetrix U-133A housekeeping genes, respectively, were utilized.BMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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methodologies differed in the number of genes defined as
down- or up-regulated in expression in PT3 compared to
PT1 and NK cell lines, all identified the same 7 up-regu-
lated genes (PCNA, POLD1, RFC3, RFC4, RFC5, RPA1,
and RPA2) except RPA1 in normalization using HG-
U133A housekeeping genes (Table 1). This finding sug-
gested that these seven genes were clearly differentially
over-expressed in PT3 versus PT1 and NK cell lines.
Verification of microarray results by real-time quantitative 
PCR
As we did the microarray analysis using a single mRNA
isolation/cDNA probe analysis, we needed to verify the
transcriptional over-expression of these seven genes by
real-time quantitative PCR. To determine the optimum
amount of cDNA template in initial experiments, we per-
formed undiluted, 1:10 diluted, and 1:100 diluted cDNA
template in parallel. Gene expression of NK, PT1 and PT3
cDNA templates were normalized to the Ct value of refer-
ence genes: GAPDH or ACTB, respectively, to calculate the
Ct values of PCNA, POLD1, RFC3, RFC4, RFC5, RPA1,
and RPA2. We used NK as calibrator (Figure 2A and 2B).
The RT-qPCR results confirmed the microarray results,
that PCNA, POLD1, RFC3, RFC4, RFC5, RPA1, and RPA2
were over-expressed in PT3 (at least a 1.8 fold difference
between two groups [PT3 vs Non-PT3]). The relative
quantitative expression of the 7 genes between PT3 and
Non-PT3 samples was set at a significance level of 0.05. To
see the comparative gene expression levels of PCNA,
POLD1, RFC3, RFC4, RFC5, RPA1, and RPA2, comparing
the microarray and qPCR results, we used non-PT3 (NK
and PT1) cells as the calibrator (Figure 3A and 3B).
Super-permissiveness does not correlate with cytotoxicity
It has been reported in CNN in 2005, in work done by
Craig Meyers, that AAV preferentially kills cancer cells
http://www.cnn.com/2005/HEALTH/06/22/cancer.virus/
. This reported cancer cell killing may be related to parvo-
virus replication as certain parvoviruses have been
reported to preferentially replicate in malignant cells [44].
Thus we tested the high and low AAV-permissive cells for
their sensitivity to killing by AAV infection. The results are
shown in Figure 4 and demonstrate that PT3 was not pref-
erentially sensitive to killing by AAV2 infection compared
to other squamous cells.
Discussion
Earlier studies by Ni et al and Nash et al identified a
number of cellular components which are required for in
vitro AAV DNA replication using both adenovirus-infected
and uninfected cell extracts [41,42]. These cellular compo-
nents, found to be critical, include PCNA, RFC, RPA and
DNA polymerase delta (POLD1). This study demonstrates
that the PT3 primary cervical cancer cell isolate, which is
super-permissive for AAV replication [40], over-expresses
all four of these components, when compared with PT1/
NK. Thus, the data presented here are fully consistent with
the earlier in vitro studies, but now extend these studies
Table 2: DNA helicase expression. 
Probe set Description Gene symbol PT3 Non-PT3 Fold Differences
ACTB GAPDH U133-A ACTB GAPDH U133-A ACTB GAPDH U133-A
34063_at RecQ protein-like 5 RECQL5 - - - - - - - - -
202420_s_at DEAH (Asp-Glu-Ala-His) 
box polypeptide 9
D H X 9 -- --- --- -
205091_x_at RecQ protein-like 
(DNA helicase Q1-like)
RECQL - - - - - - - - -
210309_at RecQ protein-like 5 RECQL5 - - - - - - - - -
210568_s_at RecQ protein-like 
(DNA helicase Q1-like)
RECQL - - - - - - - - -
211468_s_at RecQ protein-like 5 RECQL5 - - - - - - - - -
212105_s_at DEAH (Asp-Glu-Ala-His) 
box polypeptide 9
DHX9 10.3 10.4 - 9.1 9.1 2.3 2.4
212107_s_at DEAH (Asp-Glu-Ala-His) 
box polypeptide 9
D H X 9 -- --- --- -
212917_x_at RecQ protein-like 
(DNA helicase Q1-like)
RECQL 10.6 10.7 - 9.5 9.6 2.2 2.3 -
212918_at RecQ protein-like 
(DNA helicase Q1-like)
RECQL - - - - - - - - -
213520_at RecQ protein-like 4 RECQL4 - - - - - - - - -
213647_at DNA2 DNA replication 
helicase 2-like (yeast)
DNA2L 8.6 8.7 8.7 10.2 10.2 10.2 -3.0 -2.8 -2.8
213878_at similar to CG10721-PA LOC642732 - - - - - - - - -
221686_s_at RecQ protein-like 5 RECQL5 - - - - - - - - -
Three different methods for data normalization using ACTB, GAPDH, and Affymetrix U-133A housekeeping genes, respectively were utilized.BMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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into the context of the living cell. These data also further
characterize the primary cervical cancer isolate PT3 and
confirms the ability of AAV to replicate in SSE, now
including malignant cells [34-36]. It is also confirmed that
AAV2 variably replicates in multiple cervical cancer iso-
lates [40]. Thus far, to our knowledge, only the PT3 isolate
has been described as super-permissive for AAV replica-
tion, this being when compared to a variety of cells of
squamous origin.
Both the Affymetrix DNA microarray data and real-time
quantitative PCR results demonstrated that all four of
these cellular components were over expressed in PT3
cells. POLD1 and PCNA were strongly over-expressed in
PT3. Moreover, multiple RFC and RPA family members
were over-expressed in PT3. Thus, these data support the
unusual phenotype of PT3 cells and suggest their use as a
unique reagent for identifying critical genes involved in
AAV replication. This phenotype also suggests the possi-
bility that PT3, itself, may be useful as a platform for rAAV
production. One issue against this idea is that AAV repli-
cation in PT3 takes place during cellular differentiation
(induced by air interface and calcium). During such differ-
entiation cells of keratinocyte origin become highly kerat-
inized and become physically very stable, somewhat
similar to a ''piece of plastic''. This is problematic for the
efficient isolation of rAAV from keratinized PT3 cells.
However this possibility is worth investigating.
Ni et al and Nash et al [41,42] identified POLD1 as the
central DNA polymerase, which is a leading strand DNA
polymerase, the main mechanism through which AAV
DNA replication takes place. The need of PCNA and RFC
is also compatible with POLD1 as the main AAV-polymer-
ase as PCNA is the processivity factor for POLD1, and RFC
is known to assemble PCNA onto 3'OH primers. RPA was
not found essential when using adenovirus-infected cell
extracts, in contrast to uninfected cell extracts [41]. In any
case these data are also consistent with Christensen and
Tattersall [43] who found that these same four proteins
(POLD1, RPA, PCNA, and RFC) were the minimum cellu-
lar factors required for MVM DNA rolling-circle replica-
tion when using a 3'-dimer junction. However their in
vitro reactions also included MVM NS1 protein and cellu-
lar PIF protein.
In the latest study by Nash et al [41] it was mentioned that
there is one additional protein component (present in P-
Cell IA) which was needed but was unidentified. It was
further speculated that it was a cellular helicase. To
approach this question we revisited the PT3vsPT1/NK
DNA microarray data to observe if particular DNA heli-
cases or overall helicase activity was higher in PT3. This
approach seems valid as even though we have not done
the usual triple-DNA microarray analysis, the real-time
quantitative PCR expression data fully confirmed the
DNA microarray results across multiple genes. Thus, the
Affymetrix microarray data we have in hand appears wor-
thy of study for gleaning suggestive information on the
AAV-permissive transcriptome. It was found, as shown in
Table 2, that the overall helicase activity was not signifi-
cantly different in PT3 cells, with two helicases being up-
regulated and one down-regulated in PT3 versus NK/PT1.
While POLD1 was clearly found required for AAV in vitro
replication by Nash et al [41] there is a possibility the
DNA Polymerase alpha might be involved in certain
"alternative" forms of AAV DNA replication, such as
through the use of internal origins of replication [45].
Both SV40 and parvovirus H-1 are able to use Polymerase
alpha for replication [46,47]. To approach this question
we revisited the PT3vsPT1/NK DNA microarray data to
observe if DNA polymerase alpha was higher in PT3. The
results of the Affymetrix data are shown in Table 3, and
suggest that DNA polymerase alpha is also significantly
up-regulated in PT3 over PT1 and NK. However, the
importance of this up-regulation, if any, is not yet deter-
mined.
One question which arises from this data is how or if the
four components are coordinately up-regulated in PT3
cells. As we are analyzing the RNA expression of these
genes transcriptional regulation is the most likely explana-
tion and it is possible that a common transcription factor
regulates them all. Possible examples for such coordi-
nated transcriptional regulation include transcription fac-
Table 3: Expression of DNA polymerase alpha. 
Probe set Description Gene symbol PT3 Non-PT3 Fold Differences
ACTB GAPDH U133-A ACTB GAPDH U133-A ACTB GAPDH U133-A
204441_s_at Polymerase (DNA 
directed), alpha 1
POLA1 - - - - - - - - -
204835_at Polymerase (DNA 
directed), alpha 1
POLA1 11.7 11.8 11.8 10.1 10.1 10.1 2.9 3.1 3.1
Three different methods for data normalization using ACTB, GAPDH, and Affymetrix U-133A housekeeping genes, respectively were utilized.BMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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tors hDREF, CFDD, p53, and Sp1, among others. One
anecdotal finding needs to be mentioned about the PT3
cell isolate, that being its high sensitivity to culture condi-
tions. PT3 cell cultures, when grown side by side with PT1
and NK, would go into a period of en masse cell death if
not fed in a timely fashion, or kept out of the incubator for
too long. PT1 and NK cells were resistant to such die-offs
under similar culture conditions. In any case, the isolation
Real-time quantitative PCR analysis of differentially expressed  transcripts in NK, PT1 (upward diagonal bars) and PT3 (open  bars) Figure 2
Real-time quantitative PCR analysis of differentially 
expressed transcripts in NK, PT1 (upward diagonal 
bars) and PT3 (open bars). Data are expressed relative 
to ACTB (2A) and GAPDH (2B) mRNA and (*) presented p 
< 0.05. Fold-expression changes were calculated using the 
equation 2-ΔΔCT [5]. Error bars for each column in the plot 
provided that the associated expression level was calculated 
from 3 replicates. The error bars display the calculated maxi-
mum (RQMax) and minimum (RQMin) expression levels that 
represent standard error of the mean expression level (RQ 
value). Collectively, the upper and lower limits defined the 
region of expression within which the true expression level 
value was likely to occur. The error bars was based on the 
RQMin/Max confidence level. The number associated with 
each bar indicates the linear fold-change of mRNA expres-
sion in PT1 and PT3 relative to NK for comparison.
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Real-time quantitative PCR analysis (open bars) of genes  selected from the microarray (close bars) in PT3 and Non- PT3 Figure 3
Real-time quantitative PCR analysis (open bars) of 
genes selected from the microarray (closed bars) in 
PT3 and Non-PT3. Data are expressed relative to ACTB 
(3A) and GAPDH (3B) mRNA and (*) presented p < 0.05. 
The gene expression levels were sorted by detector. Gene 
expression levels for PT3 are indicated by the black bar. This 
color also indicates the sample in the RQ sample grid and the 
RQ results panel plots. Because NK samples are used as cali-
brator, the expression levels are set to 1. But because the 
gene expression levels were plotted as log10 values (and the 
log10 of 1 is 0), the expression level of the calibrator samples 
appear as 0 in the graph. In addition, because the relative 
quantities as the targets are normalized against the relative 
quantities of the reference genes, the expression level of the 
reference genes is 0, that is, there are no bars for ACTB and 
GAPDH. Fold-expression changes were calculated using the 
equation 2-ΔΔCT [5]. Error bars for each column in the plot 
provided that the associated expression level was calculated 
from 3 replicates. The error bars display the calculated maxi-
mum (RQMax) expression levels that represent standard 
error of the mean expression level (RQ value). Collectively, 
the upper and lower limits defined the region of expression 
within which the true expression level value was likely to 
occur. The error bars was based on the RQMin/Max confi-
dence level. The number associated with each bar indicates 
the linear fold-change of mRNA expression in PT3 relative to 
Non-PT3 for comparison.
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and characterization of the novel PT3 cell line gives us a
unique reagent to investigate the optimal cellular tran-
scriptome needed for AAV2 replication. Such knowledge
will be useful for understanding AAV molecular biology,
for generating high yield rAAV virus for gene therapy, and
for understanding AAV's anti-cancer properties.
Conclusion
The novel cell line PT3 is super-permissive for AAV DNA
replication and over-expresses DNA polymerase δ, PCNA,
RFC and RPA. This is important as in vitro studies by Ni et
al and Nash et al have identified these same cellular com-
ponents as being involved in AAV DNA replication in
vitro. Our in vivo data and the in vitro data of others,
together, strongly suggest that the PT3 cell line is a unique
reagent which can be used to investigate the optimal cel-
lular transcriptome which is needed for AAV replication.
The further "mining" of PT3vsPT1/NK microarray data to
intimate additional AAV-relevant genes will ultimately
give us better understanding of AAV molecular biology,
better understanding of AAV's anti-cancer properties, and
ultimately allow for higher yields in the production of
rAAV virus for gene therapy.
Methods
Cell lines
Primary human foreskin keratinocytes (NK) were pur-
chased from Clonetics Inc.(San Diego, CA). PT1, PT2, and
PT3 primary cell lines were isolated from three cervical
cancer patients as described previously [48]. These cervical
cancer isolates were at approximately passage 10–15
when used in these experiments. CaSki and SiHa cervical
cancer cell lines were purchased from American Type Cul-
ture Collection (Rockville, MD). All the cells were cul-
tured in keratinocyte serum-free medium (Invitrogene,
Carlsbad, CA) in 37°C under 5% CO2 prior to raft forma-
tion.
AAV replication in squamous cells using the organotypic 
epithelial raft cultures
On day 1, 106 normal primary keratinocytes, three pri-
mary cervical cancer cells and CaSki, SiHa cells were
infected with 108 infectious units of wild type AAV-2 virus
(multiplicity of infection [moi] = 100). On day 2 the cells
were trypsinized, plated onto J2-containing collagen rafts
as described previously [34-37]. On day 3 these organo-
typic skin rafts were raised to the air interface and allowed
to form an SSE over a period of 3 days (day 6 overall)
using E medium. Southern blot analysis was done to
detect AAV DNA replication. Rafts were harvested on day
6. After washing with phosphate-buffered saline (PBS,
137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4.)
twice, all the rafts were minced and lysed. Total DNA was
extracted and 10 μg of total cellular DNA were analyzed
for AAV DNA replication levels by agarose gel electro-
phoresis, Southern blotting, and probing with 32P-AAV
Cap DNA probe to pick up only the wt AAV genome.
Finally, a quantification of the Southern blot was done by
densitometric analysis using an Alpha Imager 2000
(Alpha Innotech Corporation, San Leandro, CA). The
densitometric data was quantified using AlphaImager™
2000 software. Densitometric data was analyzed by the
unpaired t-test and presented as mean ± standard error
(SE).
"Second plate" analysis of AAV virion production
Instead of harvesting the keratinocyte rafts for the analysis
of AAV DNA replication on day 6, in certain experiments
the SSE rafts were analyzed for AAV virion production by
the infection of a "second plate" of adenovirus infected
HEK293 cells. Putative AAV virus stocks were generated by
freezing day 6 rafts and grinding the rafts with mortar and
pestle. The remains of the raft were placed in one ml of
DMEM medium, vortexed for 1 minute and centrifuged at
8,000 g for 15 minutes to remove debris, and the superna-
tant was filtered through a 20 um filter. One third of the
putative virus stock was used to infect a 6 cm plate on 80%
Lack of cytotoxicity by AAV Figure 4
Lack of cytotoxicity by AAV. Various squamous cell iso-
lates were grown in culture and infected with AAV2 virus as 
indicated. Note that increasing mois of AAV2 did not result 
in increased cell toxicity of PT3, and had only minimal effects 
on the cell growth of the other cells. Shown is a representa-
tive experiment of three done.
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confluent monolayer HEK293 cells. These cells were also
infected with Ad helper virus at an moi of 5. Any AAV
infectious units produced in the original raft would be
amplified in the Ad-infected 293 cells. After 36 hours of
infection total DNA was extracted and 10 μg of total cellu-
lar DNA were analyzed for AAV DNA replication levels by
agarose gel electrophoresis, Southern blotting, and prob-
ing with 32P-AAV cap DNA probe.
AAV2 cytotoxicity in cervical cancer cell isolates
AAV2 virus stock was serially diluted with Dulbecco's
medium (supplemented with 10% FBS and 100 U/ml
penicillin). Normal keratinocytes and three primary can-
cer cell lines (PT1, PT2 and PT3) were seeded (4 × 105/
dish) one day prior to infection with serially diluted wild
type AAV 2 in 1 ml culture media at a multiplicity of infec-
tion (moi) of 100, 1,000, 10,000 AAV particles. Culture
media was replaced with E medium after overnight incu-
bation at 37°C and were incubated for additional 6 days
with fresh media at one day interval. At day 7 the cells
were washed with PBS, fixed in formaldehyde and stained
with methylene blue. The experiment was done three
times.
Total RNA extraction and cDNA synthesis
For real-time quantitative PCR (qPCR), total RNA samples
from 1 × 106 cultured cells was extracted from NK, PT1
and PT3 cell lines using Total RNA Purification System Kit
(Invitrogen, USA) according to the manufacturer's proto-
col. Concentration of mRNA was quantified using Nano-
Drop®  ND-1000 Spectrophotometer (NanoDrop
technology, USA). One μg was transcribed into first strand
cDNA using Transcriptor First Strand cDNA Synthesis Kit
(Roche, Indianapolis, IN) according to the manufacturer's
protocol. For Affymetrix microarray analysis, total RNA
was isolated from NK, PT1 and PT3 cell lines using Trizol
(Invitrogen, Carlsbad, CA) according to the manufac-
turer's protocol. After treatment with 5 U/μg of RNase-free
DNase I at 37°C for 1 hour, all the samples were frozen in
and sent to University of Iowa DNA facility for microarray
analysis. After cDNA synthesis, samples were applied to a
Human Genome GeneChip HG-U133A (Affymetrix Inc.
Santa Clara, CA).
Array filtering and significant expressed gene identification
Microarray data in the form of CEL files were imported
into BRB ArrayTools developed by Dr. Richard Simon and
Amy Peng Lam http://linus.nci.nih.gov/BRB-Array
Tools.html. HG-U133A microarray raw expression inten-
sities of NK, PT1, and PT3 data were scaled to a target
intensity of 100 units, normalized independently, using
the robust multichip average (RMA) algorithm for the
quantification of the expression level of target genes, and
passed by the filtering and subletting criteria with any one
absent (A) or marginal call (M). Genes that had more than
50% missing data across all observations were excluded
from the analysis. Also, we selected those genes with an
expression level of ≥ 20 in ≥ 25% of samples. Fold change
has been transformed based on log2 (PT1/NK), log2(PT3/
NK), log2 (PT3/PT1), log2 (PT3/non-PT3), respectively.
Fold change above 2.0 was defined as differentially
expressed genes between two cell lines, where it is meet
fold >2 SD (above 97% confidence).
Real-time quantitative PCR
Validation of differential expressed genes was done by
real-time quantitative PCR (RT-qPCR). RT-qPCR assays
were performed using the Applied Biosystems 7500 Sys-
tems (Applied Biosystems, USA). Each sample was run in
triplicate to ensure quantitative accuracy. We used Human
Universal ProbeLibrary from Roche Applied Science.
Assay specificity was attained through the combination of
specific primers designed from ProbeFinder https://
www.roche-applied-science.com) web-based software.
Seven genes, plus two reference genes, with their specific
primers, and PCR product size information for real-time
quantitative PCR validation are listed in Table 4.
All PCR reactions were carried out in a final volume of 50
μl containing 1× of FastStart Universal SYBR Green Master
Table 4: Primer information for real-time qPCR.
Gene name Size (bp) Forward primer sequence (5' – 3') Reverse primer sequence (5' – 3')
PT3-inducible genes
PCNA 66 GAACTGGTTCATTCATCTCTATGG TGTCACAGACAAGTAATGTCGATAAA
POLD1 107 AGGTAGTACTGCGTGTCAATGG CCCTACGTGATCATCAGTGC
RFC3 69 CACAGTAGATAACACGTGGCAAA AGTAGGTGCTTGGCGGTTC
RFC4 77 TTCCAGGTGGTCCGTAAAAC AGAAGTGGTTGCAGTGCTGA
RFC5 84 TGTGGCCGGTATTTTTCAAC GGAGACCTCAGCACTCAAGC
RPA1 65 CCGTAGTAATGGGACGGATG GCAGAAGGGGGATACAAACA
RPA2 95 TTCCAGAATATGTGTGGTGAACTC GCCACCTGAGATCTTTTCAGA
Reference genes
ACTB 97 CCAGAGGCGTACAGGGATAG CCAACCGCGAGAAGATGA
GAPDH 66 GCCCAATACGACCAAATCC AGCCACATCGCTCAGACACBMC Microbiology 2009, 9:79 http://www.biomedcentral.com/1471-2180/9/79
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[ROX] (Roche Applied Science, USA) with a reporter dye
at the 5' end (FAM) and a quencher at the 3' end, 300 nM
of each gene specific primers (Table 1), 50 ng cDNA, and
then added sterile deionized water. The standard cycling
condition was 50°C for 2 min, 90°C for 10 min, followed
by 40 cycles of 95°C for 15 s and 60°C for 1 min.
To quantify the relative expression of each gene, real-time
qPCR data were first reported as (1) NK: PT1 and PT3 as
well as (2) non-PT3 (NK and PT1):PT3 ratios. The com-
parative threshold cycle (Ct) values for NK, PT1, and PT3
samples were normalized for reference genes (ΔCt = Ct target
- Ct ACTB or GAPDH) and compared with a calibrator using the
ΔΔCt method [49]. As calibrator, the average Ct value of
each gene in all samples grouped together was taken. All
reported real-time quantitative PCR reactions were per-
formed and analyzed using an ABI 7500 System SDS Soft-
ware Ver1.3 (Applied Biosystems, USA). Fold units were
calculated dividing the expression fold changes of the can-
didate genes by the expression fold changes of the refer-
ence gene (ACTB or GAPDH).
Statistical analysis
Comparison of the relative quantitative expression of the
7 genes between PT3 and Non-PT3 samples was done
with an unpaired t-test comparing two groups, with a sig-
nificance level of 0.05 using Microsoft Excel 2003 pro-
gram and presented as mean ± standard error (SE). All real
time quantitative PCR were performed in triplicate to
ensure quantitative accuracy.
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